Uri Sagman
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances
Papers in
- Epidemiology 12
- Neuroendocrine Tumor Research Advances 11
- Oncology 11
- Lung Cancer Research Studies 10
- Peptidase Inhibition and Analysis 4
- Co-authors
- James W. Dennis (1 shared paper)J. Fernandes (1 shared paper)Manon Auger (1 shared paper)Monica De Metrio (1 shared paper)William K. Evans (6 shared papers)J L Yeoh (4 shared papers)David G. Payne (4 shared papers)Ellen Maki (4 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Lung Cancer (2 papers)Blood (2 papers)Cancer (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- CanadaUnited StatesIndia
In The Last Decade
Uri Sagman
19 papers receiving 879 citations
Peers
Comparison fields: 5 of 64
- Oncology 461
- Epidemiology 355
- Immunology 177
- Pulmonary and Respiratory Medicine 231
- Molecular Biology 381
Countries citing papers authored by Uri Sagman
This map shows the geographic impact of Uri Sagman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Sagman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Sagman more than expected).
Fields of papers citing papers by Uri Sagman
This network shows the impact of papers produced by Uri Sagman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Sagman. The network helps show where Uri Sagman may publish in the future.
Co-authors
The 25 scholars most cited alongside Uri Sagman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. | 1991 | 318 |
| 2 | 1991 | 119 | |
| 3 | 1991 | 75 | |
| 4 | 1990 | 73 | |
| 5 | 1992 | 61 | |
| 6 | 1993 | 60 | |
| 7 | 1990 | 51 | |
| 8 | 1990 | 37 | |
| 9 | 1989 | 30 | |
| 10 | 1989 | 24 | |
| 11 | 1989 | 12 | |
| 12 | 1988 | 10 | |
| 13 | 1989 | 8 | |
| 14 | 1988 | 8 | |
| 15 | The isolation of the human delta chain gene and its expression in normal T cells and T cell leukemias. | 1988 | 8 |
| 16 | 1995 | 7 | |
| 17 | 1989 | 2 | |
| 18 | Évaluation de classifications par le critère d'Akaike et la validation croisée | 1988 | 1 |
| 19 | 1989 | 1 |
About Uri Sagman
Uri Sagman is a scholar working on Epidemiology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 19 papers that have together received 905 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Research Studies (10 papers), Peptidase Inhibition and Analysis (4 papers), Lung Cancer Treatments and Mutations (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (461 citations), Epidemiology (355 citations), Immunology (177 citations), Pulmonary and Respiratory Medicine (231 citations) and Molecular Biology (381 citations). Uri Sagman has collaborated with scholars based in Canada, United States and India. Frequent co-authors include James W. Dennis, J. Fernandes, Manon Auger, Monica De Metrio, William K. Evans, J L Yeoh, David G. Payne, Ellen Maki, Frances A. Shepherd and Riad Haddad. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Blood, Cancer and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.